Anything that indicates information about a cancer, such as its aggressiveness, potential response to treatment, or state of response to treatment, that is either present in or produced by cancer cells, other cells of the body, or both in response to cancer or certain benign (noncancerous) conditions is called a tumor marker. Major databases such as Medline were explored detailed literature search in resulting in a systematic review pertaining to p63. Three research scientific articles dated between 2020‐2024 pertaining to p63 were highlighted. Tumor markers have generally been proteins or other chemicals that are generated at larger concentrations by cancer cells than normal ones. Some cancer patient’ blood, urine, faeces, tumors and other tissues and body fluids may include these. Detailed information regarding p63 and its vital role in the field of pathology and oncology is discussed in this systematic review.
Teena Eugene, Vinutha Gali and Karthik Shunmugavelu. Vital Role of P63 in the Field of Pathology and Oncology Pertaining to Adult and Paediatric Population A Systematic Review.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.5.225.231
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.5.225.231